HSKA News and Press, Heska Corporation From 04/05/23

NEW YORK, NY / ACCESSWIRE / April 5, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Heska Corporation (NASDAQ:HSKA)'s s...

2023-04-03 11:31:40 ET Mars, the fourth-largest privately held company in the U.S., has agreed to buy the pet diagnostics and specialty products company Heska (NASDAQ: HSKA) for $120 per share. In response to this news, the stock was up by a hefty 20.6% on heavy volume as of 10:...

2023-04-03 10:02:08 ET Gainers: Heska ( HSKA ) +20% . Heron Therapeutics ( HRTX ) +19% . InterCure ( INCR ) +17% . Innate Pharma ( IPHA ) +15% . Apellis Pharmaceuticals ( APLS ) +14% . Losers: OncoSec Medical ( ONCS...

2023-04-03 08:50:25 ET Heska ( NASDAQ: HSKA ) shares were trading ~21% higher Monday pre-market after Mars agreed to acquire the advanced veterinary diagnostic and specialty products company for $120 per share. The purchase price represents a premium of ~23% over Heska's Mar. ...

Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions PR Newswire The combination of highly complementary businesses and teams will broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more...

Heska Corporation (HSKA) Q4 2022 Earnings Conference Call February 28, 2023 11:00 AM ET Company Participants Jon Aagaard - Investor Relations Kevin Wilson - Chief Executive Officer and President Catherine Grassman - Chief Financial Officer Conference Call Partici...

The following slide deck was published by Heska Corporation in conjunction with their 2022 Q4 earnings call. For further details see: Heska Corporation 2022 Q4 - Results - Earnings Call Presentation

Heska press release ( NASDAQ: HSKA ): Q4 Non-GAAP EPS of $0.55 beats by $0.22 . Revenue of $66.34M (-2.5% Y/Y) beats by $1.72M . FY2023 Outlook : Consolidated Revenue of $278M to $288M vs. consensus of $279.06M. For further details see: Heska Non-GAAP EPS...

Heska Corporation Reports Fourth Quarter and Full Year 2022 Results PR Newswire Full Year Sales $257.3 Million , Full Year Gross Margin Up 150 Basis Points to 43.2% Full Year North America Lab Consumables Sales Up 8.7%, Total Active Subscriptions Up 18% L...

Heska to Present at Three Upcoming Institutional Investor Conferences PR Newswire LOVELAND, Colo. , Feb. 23, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic a...